BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18235887)

  • 1. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.
    Wolfson LJ; Gasse F; Lee-Martin SP; Lydon P; Magan A; Tibouti A; Johns B; Hutubessy R; Salama P; Okwo-Bele JM
    Bull World Health Organ; 2008 Jan; 86(1):27-39. PubMed ID: 18235887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
    Sim SY; Watts E; Constenla D; Huang S; Brenzel L; Patenaude BN
    Value Health; 2021 Jan; 24(1):70-77. PubMed ID: 33431156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
    Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
    Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS).
    Brown DW; Burton A; Gacic-Dobo M; Karimov RI; Vandelaer J; Okwo-Bele JM
    BMC Public Health; 2011 Oct; 11():806. PubMed ID: 21999521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
    Ozawa S; Clark S; Portnoy A; Grewal S; Stack ML; Sinha A; Mirelman A; Franklin H; Friberg IK; Tam Y; Walker N; Clark A; Ferrari M; Suraratdecha C; Sweet S; Goldie SJ; Garske T; Li M; Hansen PM; Johnson HL; Walker D
    Bull World Health Organ; 2017 Sep; 95(9):629-638. PubMed ID: 28867843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030.
    Sriudomporn S; Watts E; Yoon Sim S; Hutubessy R; Patenaude B
    Vaccine X; 2023 Apr; 13():100256. PubMed ID: 36686400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
    Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
    Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global costs of attaining the Millennium Development Goal for water supply and sanitation.
    Hutton G; Bartram J
    Bull World Health Organ; 2008 Jan; 86(1):13-9. PubMed ID: 18235885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global immunization: status, progress, challenges and future.
    Duclos P; Okwo-Bele JM; Gacic-Dobo M; Cherian T
    BMC Int Health Hum Rights; 2009 Oct; 9 Suppl 1(Suppl 1):S2. PubMed ID: 19828060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries.
    Kamara L; Lydon P; Bilous J; Vandelaer J; Eggers R; Gacic-Dobo M; Meaney W; Okwo-Bele JM
    Health Policy Plan; 2013 Jan; 28(1):11-9. PubMed ID: 22411879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study.
    Chaitkin M; McCormick S; Alvarez-Sala Torreano J; Amongin I; Gaya S; Hanssen ON; Johnston R; Slaymaker T; Chase C; Hutton G; Montgomery M
    Lancet Glob Health; 2022 Jun; 10(6):e840-e849. PubMed ID: 35397226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.